A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Pembrolizumab Versus Placebo as Adjuvant Therapy Following Surgery and Radiation in Participants with High-risk Locally Advanced Cutaneous Squamous Cell Carcinoma (LA cSCC) (KEYNOTE-630).

  • Chipman, Mitchell (Primary Chief Investigator (PCI))
  • Hawkins, Cheryl-Ann (Project Manager)
  • Cross, Nikki (Project Manager)

Project: Research

Project Details

Effective start/end date12/08/1931/12/24


  • Medical Oncology
  • Squamous cell carcinoma
  • Clinical trial